Study populations

Brazil, in 2016, had an estimated population of 209.5m with 23% under the age of 15 years and only 8% over the age of 65 years, yet this is predicted to dramatically change in the decades to come despite its increasing population. By 2050, over 1 in 5 people (15%, 54.8m) will be over the age of 65 years, whereas only 15% will be under the age of 15 years.

Alongside the ageing population, diabetes prevalence is increasing – with the most recent statistics reporting 14.3m people living with the condition and an estimated 5.76m undiagnosed cases. Brazil will remain in the top 10 countries for the highest adult population with diabetes in 2050 at an estimated 23.3m.

Time of presentation for screening with an ophthamologist

13.2% In time for screening, 79.2% When visual problems have already occurred, 7.5% Too late for effective treatment
(Ophthamologists n=53)
In time for screening When visual problems have already occurred Too late for effective treatment

Availability of DR patient education materials in health care providers’ offices

26.7% Sufficient information available, 14% Information not sufficient, 53.5% No written information available, 5.8% Don’t know
(All providers n=86)
Sufficient information available Information not sufficient No written information available Don’t know

Complications adults with diabetes were most concerned about

47.7% Vision loss, 20.3% Cardiovascular disease/stroke, 14.8% Amputation, 14.8% Kidney disease
(Adults with diabetes n=128)
Vision loss Cardiovascular disease/stroke Amputation
Kidney disease

Frequency of discussions about eye complications with health care providers

36.6% Every visit, 13.8% Multiple times per year, 20.3% Once a year, 17.1% When symptoms arise, 10.6% Never
(Adults with diabetes n=123)
Every visit Multiple times per year Once a year When symptoms arise Never

The DR Barometer Community is a growing multidisciplinary network of thought leaders and organizations who are working together to address gaps in diabetes patient care. Join today to help improve vision health outcomes among people living with diabetes.